CA Stock MarketDetailed Quotes

Neural Therapeutics Inc (NURL)

Watchlist
  • 0.020
  • 0.0000.00%
15min DelayMarket Closed May 13 13:07 ET
3.38MMarket Cap-2.50P/E (TTM)

Neural Therapeutics Inc (NURL) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jan 31, 2026
(Q1)Oct 31, 2025
(FY)Jul 31, 2025
(Q4)Jul 31, 2025
(Q3)Apr 30, 2025
(Q2)Jan 31, 2025
(Q1)Oct 31, 2024
(FY)Jul 31, 2024
(Q4)Jul 31, 2024
(Q3)Apr 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-597.35%-52.01K
-4,967.84%-50.58K
1.43%-315.34K
-42.68%-32.32K
-487.57%-274.57K
-193.00%-7.46K
99.61%-998
39.29%-319.93K
78.81%-22.65K
17.62%-46.73K
Net income from continuing operations
-237.22%-390.64K
35.89%-64.5K
-54.06%-1.03M
182.33%172.1K
-700.29%-981.74K
34.36%-115.84K
36.27%-100.6K
38.11%-666.03K
-13.98%-209.03K
58.16%-122.67K
Operating gains losses
--276K
---9.08K
---32.07K
---716.67K
----
----
----
----
----
----
Remuneration paid in stock
----
----
--409.04K
----
----
----
----
--0
----
-8.54%7.5K
Other non cashItems
----
----
217.30%149.51K
1,817.11%148.35K
--802
---7.5K
-60.01%7.86K
-62.26%47.12K
--7.74K
----
Change In working capital
-45.95%62.63K
-74.93%23K
-38.37%184.26K
-125.27%-45.14K
-68.20%21.77K
-32.73%115.88K
176.23%91.75K
-46.64%298.98K
-14.27%178.64K
-70.02%68.44K
-Change in receivables
-97.31%517
77.05%-533
-49.57%21.01K
633.00%32.69K
-646.56%-28.56K
372.62%19.2K
-103.96%-2.32K
323.37%41.65K
71.95%-6.13K
-113.69%-3.83K
-Change in prepaid assets
--12.27K
--5K
-346.13%-19.69K
--4.85K
---24.54K
--0
--0
-66.67%8K
--0
--0
-Change in payables and accrued expense
123.72%49.85K
-80.30%18.53K
-482.38%-64.75K
-81.57%34.32K
110.55%17.05K
-218.55%-210.19K
150.84%94.07K
-96.95%16.93K
-13.38%186.25K
-185.70%-161.6K
-Change in other current assets
----
----
200.00%1.57K
--0
--1.57K
----
----
---1.57K
---1.57K
--0
-Change in other current liabilities
----
----
5.20%246.13K
-130,100.00%-117K
-75.95%56.25K
----
----
--233.96K
--90
--233.87K
Cash from discontinued investing activities
Operating cash flow
-597.35%-52.01K
-4,967.84%-50.58K
1.43%-315.34K
-42.68%-32.32K
-487.57%-274.57K
-193.00%-7.46K
99.61%-998
39.29%-319.93K
78.81%-22.65K
17.62%-46.73K
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
265.02%413.93K
-181.37%-53.69K
5.89K
585.11%461.74K
0
-73.53%113.4K
-23.92%65.99K
0
Net issuance payments of debt
----
----
-217.35%-12.91K
-104.65%-511
---12.69K
----
----
--11K
--11K
--0
Net common stock issuance
----
----
304.68%465.32K
-196.72%-53.18K
--57.05K
584.81%461.45K
--0
-73.16%114.99K
-36.09%54.99K
--0
Net other financing activities
----
----
-205.72%-38.48K
--2
----
----
----
---12.59K
--0
--0
Cash from discontinued financing activities
Financing cash flow
----
----
265.02%413.93K
-181.37%-53.69K
--5.89K
585.11%461.74K
--0
-73.53%113.4K
-23.92%65.99K
--0
Net cash flow
Beginning cash position
74.49%114.8K
147.61%165.38K
-75.56%66.79K
971.82%251.39K
641.01%520.07K
-58.19%65.79K
-75.56%66.79K
-26.50%273.32K
-92.01%23.45K
7.15%70.18K
Current changes in cash
-111.45%-52.01K
-4,967.84%-50.58K
147.73%98.59K
-298.47%-86.01K
-474.97%-268.68K
621.19%454.28K
99.14%-998
-109.56%-206.53K
315.17%43.34K
-120.50%-46.73K
End cash Position
-87.93%62.79K
74.49%114.8K
147.61%165.38K
147.61%165.38K
971.82%251.39K
641.01%520.07K
-58.19%65.79K
-75.56%66.79K
-75.56%66.79K
-92.01%23.45K
Free cash from
-597.35%-52.01K
-4,967.84%-50.58K
1.43%-315.34K
-42.68%-32.32K
-487.57%-274.57K
-193.00%-7.46K
99.61%-998
39.29%-319.93K
78.81%-22.65K
17.62%-46.73K
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jan 31, 2026(Q1)Oct 31, 2025(FY)Jul 31, 2025(Q4)Jul 31, 2025(Q3)Apr 30, 2025(Q2)Jan 31, 2025(Q1)Oct 31, 2024(FY)Jul 31, 2024(Q4)Jul 31, 2024(Q3)Apr 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -597.35%-52.01K-4,967.84%-50.58K1.43%-315.34K-42.68%-32.32K-487.57%-274.57K-193.00%-7.46K99.61%-99839.29%-319.93K78.81%-22.65K17.62%-46.73K
Net income from continuing operations -237.22%-390.64K35.89%-64.5K-54.06%-1.03M182.33%172.1K-700.29%-981.74K34.36%-115.84K36.27%-100.6K38.11%-666.03K-13.98%-209.03K58.16%-122.67K
Operating gains losses --276K---9.08K---32.07K---716.67K------------------------
Remuneration paid in stock ----------409.04K------------------0-----8.54%7.5K
Other non cashItems --------217.30%149.51K1,817.11%148.35K--802---7.5K-60.01%7.86K-62.26%47.12K--7.74K----
Change In working capital -45.95%62.63K-74.93%23K-38.37%184.26K-125.27%-45.14K-68.20%21.77K-32.73%115.88K176.23%91.75K-46.64%298.98K-14.27%178.64K-70.02%68.44K
-Change in receivables -97.31%51777.05%-533-49.57%21.01K633.00%32.69K-646.56%-28.56K372.62%19.2K-103.96%-2.32K323.37%41.65K71.95%-6.13K-113.69%-3.83K
-Change in prepaid assets --12.27K--5K-346.13%-19.69K--4.85K---24.54K--0--0-66.67%8K--0--0
-Change in payables and accrued expense 123.72%49.85K-80.30%18.53K-482.38%-64.75K-81.57%34.32K110.55%17.05K-218.55%-210.19K150.84%94.07K-96.95%16.93K-13.38%186.25K-185.70%-161.6K
-Change in other current assets --------200.00%1.57K--0--1.57K-----------1.57K---1.57K--0
-Change in other current liabilities --------5.20%246.13K-130,100.00%-117K-75.95%56.25K----------233.96K--90--233.87K
Cash from discontinued investing activities
Operating cash flow -597.35%-52.01K-4,967.84%-50.58K1.43%-315.34K-42.68%-32.32K-487.57%-274.57K-193.00%-7.46K99.61%-99839.29%-319.93K78.81%-22.65K17.62%-46.73K
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities 265.02%413.93K-181.37%-53.69K5.89K585.11%461.74K0-73.53%113.4K-23.92%65.99K0
Net issuance payments of debt ---------217.35%-12.91K-104.65%-511---12.69K----------11K--11K--0
Net common stock issuance --------304.68%465.32K-196.72%-53.18K--57.05K584.81%461.45K--0-73.16%114.99K-36.09%54.99K--0
Net other financing activities ---------205.72%-38.48K--2---------------12.59K--0--0
Cash from discontinued financing activities
Financing cash flow --------265.02%413.93K-181.37%-53.69K--5.89K585.11%461.74K--0-73.53%113.4K-23.92%65.99K--0
Net cash flow
Beginning cash position 74.49%114.8K147.61%165.38K-75.56%66.79K971.82%251.39K641.01%520.07K-58.19%65.79K-75.56%66.79K-26.50%273.32K-92.01%23.45K7.15%70.18K
Current changes in cash -111.45%-52.01K-4,967.84%-50.58K147.73%98.59K-298.47%-86.01K-474.97%-268.68K621.19%454.28K99.14%-998-109.56%-206.53K315.17%43.34K-120.50%-46.73K
End cash Position -87.93%62.79K74.49%114.8K147.61%165.38K147.61%165.38K971.82%251.39K641.01%520.07K-58.19%65.79K-75.56%66.79K-75.56%66.79K-92.01%23.45K
Free cash from -597.35%-52.01K-4,967.84%-50.58K1.43%-315.34K-42.68%-32.32K-487.57%-274.57K-193.00%-7.46K99.61%-99839.29%-319.93K78.81%-22.65K17.62%-46.73K
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More